Casdin Capital
Casdin Capital is a venture capital firm dedicated to investing in the life sciences revolution. The firm focuses on healthcare, biotechnology, synthetic biology, and technology sectors, leveraging the accelerating capability to read and manipulate molecular information. Casdin Capital partners with companies to create value and open new opportunities, emphasizing patience, persistence, and strong relationships. The firm is known for its expertise in the field, aiming at big markets and investing in great ideas and teams while maintaining a disciplined and principled approach.
Casdin Capital
1350 Avenue of the Americas Suite 2600 | New York, NY 10019
Portfolio
Biotechnology and its constituents are now at the epicenter of the life science industry.
#Biotechnology
Engineered more than 1 billion viral vectors for targeted gene therapies, with capabilities in cGMP manufacturing.
#Biotechnology
Molecular traps a thousand times smaller than those in conventional mass spectrometers.
#Technology
Targets tumor cells by mimicking the immune system's natural activities, engineering T cells for high accuracy.
#Biotechnology
Based in Vancouver, WA, focuses on efficient and cost-effective development of pharmaceutical therapies.
#Biotechnology
Translating the adaptive immune system with a powerful platform.
#Biotechnology
Building a gene therapy company with novel AAV vectors to overcome conventional limitations.
#Biotechnology
Pioneering immuno-neurology for neurodegenerative diseases, targeting immune dysfunction.
#Biotechnology
Advances translational science, cell and gene therapies, offering pre-clinical models and support services.
#Biotechnology